Clinique Ovo
cliniqueovo.comTotal trials
36
Active
1
Phase 3
3
Total enrollment
20,945
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 1 of 1 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Combination therapy : Follitropin delta and HP-hMG | — | — | — | — | — | 1 |
Next readouts
- 2026-08
Top conditions
- Infertility15
- IVF4
- Fertility Disorders3
- Infertility, Male2
- Pregnancy1
- Azoospermia1
- Reproductive Disorder1
- Fertility Preservation1
Frequently asked questions about Clinique Ovo
- How many clinical trials does Clinique Ovo have on ClinicalTrials.gov?
- Clinique Ovo is listed as the lead sponsor on 36 clinical trials in ClinicalTrials.gov, 1 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Clinique Ovo's trials are in Phase 3?
- 3 of Clinique Ovo's trials are in Phase 3, spread across 1 active drug program.
- What therapeutic areas does Clinique Ovo focus on?
- Clinique Ovo's most-studied conditions on ClinicalTrials.gov are Infertility, IVF, Fertility Disorders, Infertility, Male, Pregnancy.
- When are Clinique Ovo's next clinical trial readouts?
- Clinique Ovo has 1 upcoming primary-completion readout tracked here; the soonest is “Menopur And Rekovelle Combination Study Version 2.0”, expected around 2026-08.